Clinical Trials Sponsored by GX pharma technology (beijing) Co., Ltd

Total 288 results

Overseas Pharmaceuticals, Ltd.
GX pharma technology (beijing) Co., Ltd

Active, not recruiting

An Open Label, Balanced, Randomized, 3×3 Latin Square Design Comparing of Brivaracetam Sustained-release Tablets and Brivaracetam Tablets in the Oral Comparative Pharmacokinetic(PK) Study in Chinese Healthy Adult Subjects Under Fasting Conditions.

Partial Seizure

China
Adai Technology (Beijing) Co., Ltd.

Recruiting

Digital Cognitive Behavioral Therapy for Depressive Disorders

Depression | Anxiety

China
Beijing Airdoc Technology Co., Ltd.

Recruiting

Myopia Preventing With Distance-image Screen (DIS)

Myopia, Progressive

China
Adai Technology (Beijing) Co., Ltd.

Completed

Gamified Adaptive Approach Bias Modification on Individuals With Methamphetamine Use History

Addiction, Substance

China
Essen Technology (Beijing) Co., Ltd.

Unknown

Evaluate Safety And Effectiveness Of The Tivoli® DES and The Firebird2® DES For Treatment Coronary Revascularization

Myocardial Ischemia | Coronary Disease | Acute Coronary Syndrome | Ischemic Heart Disease | Coronary Artery Lesions,Primary | Furcation Lesion of Coronary Artery

China
Adai Technology (Beijing) Co., Ltd.

Recruiting

Digital Intervention for Depression and Anxiety in Adolescents

Depression | Anxiety

China
Newish Technology (Beijing) Co., Ltd.

Recruiting

NWRD06 DNA Plasmid for HCC After Radical Resection

Hepatocellular Carcinoma

China
Newish Technology (Beijing) Co., Ltd.

Recruiting

Clinical Study of HPV Therapeutic DNA Vaccine (NWRD08) in Patients With Cervical HPV16 and/or HPV18 Positive

HSIL of Cervix

China
Adai Technology (Beijing) Co., Ltd.

Completed

Game-Based Digital Intervention for Relieving Depression and Anxiety Symptoms

Depression | Anxiety

China
Newish Technology (Beijing) Co., Ltd.

Recruiting

NWRD08 DNA Plasmid for HPV-16 and/or HPV-18 Related Cervical HSIL

High-grade Squamous Intraepithelial Lesion (HSIL)

China
Beijing Airdoc Technology Co., Ltd.

Recruiting

Real Word Study on Myopia Control With Repeated Red Light Therapy for Ages of 3~6 Years Old (RMC)

Myopia | Amblyopia

China
Adai Technology (Beijing) Co., Ltd.

Not yet recruiting

Depression in Patients With Mild to Moderate Depression

Depression
Beijing Airdoc Technology Co., Ltd.

Completed

Myopia Control With Three Lever Irradiance of PBM Therapy in Children and Adults (MCPT)

Myopia | Amblyopia | Ametropia | Refractive Error - Myopia Axial

China
Changsha Tsingray Technology Co., Ltd.

Recruiting

A Clinical Trial Evaluating the Effectiveness and Safety of a mmWave Radar Based Sleep Respiratory Monitoring System

Sleep Breathing Disorders

China
Staidson (Beijing) Biopharmaceuticals Co., Ltd
Beijing Novikang Medical Technology Co., LTD

Completed

Safety and Efficacy of STSP-0601 in Adult Patients With Hemophilia A or B Without Inhibitor

Hemophilia

China
RDO Pharm.
Beijing Pharbers Genesis Pharmaceutical Technology Co., Ltd.

Completed

A Study of 99mTc-3PRGD2 Injection in Lung Cancer Patient

Lung Cancer Metastatic

China
Lepu Medical Technology (Beijing) Co., Ltd.

Recruiting

Ultrasound Ablation for Essential Hypertension（FIM）

Uncontrolled Essential Hypertension

China
Lepu Medical Technology (Beijing) Co., Ltd.

Not yet recruiting

Long-term Efficacy of Drug-coated Balloon Versus Drug-eluting Stent in Large de Novo Coronary Lesions

Coronary Artery Disease | Drug-coated Balloon
Lepu Medical Technology (Beijing) Co., Ltd.

Recruiting

A Safety and Efficacy Study of Lepu® Drug Coated Balloon in Treatment of Coronary Small-vessel Disease

Coronary Artery Disease

China
Beijing Nuokangda Pharmaceutical Technology Co....

Unknown

Phase I Clinical Study for Evaluation of Pharmacokinetic, Safety, Tolerance of Norcantharidin Lipid Microsphere for Injection in Patients With Solid Tumor

Solid Tumor

China
Beijing QS Medical Technology Co., Ltd.

Completed

Comparison of Safety and Efficacy of QS-M Needle- Free Injector and Insulin Pen in Controlling T2DM Patient's Glucose

Diabetes

China
Lepu Medical Technology (Beijing) Co., Ltd.

Unknown

NeoVas Bioresorbable Coronary Scaffold Registry Study

Coronary Artery Disease

China
Lepu Medical Technology (Beijing) Co., Ltd.

Unknown

NeoVas Bioresorbable Coronary Scaffold Randomized Controlled Trial

Coronary Artery Disease

China
Lepu Medical Technology (Beijing) Co., Ltd.

Unknown

NeoVas Bioresorbable Coronary Scaffold First-in-Man Study

Coronary Artery Disease

China
Lepu Medical Technology (Beijing) Co., Ltd.

Not yet recruiting

Optimized Antiplatelet Therapy in Patients With CHD After Implantation of NeoVas™ BRS System

Coronary Heart Disease

China
Beijing Sanwater Biological Technology Co., Ltd.

Unknown

Efficacy of CART-19 Cell Therapy in B Cell Acute Lymphoblastic Leukemia

Acute Lymphoblastic Leukemia

China
Beijing Anzhen Hospital
Beijing Wispirit Technology Co., Ltd

Not yet recruiting

Computerized Cognitive Training to Protect Cognitive Function Among Hypertension Patients

Hypertension | Mild Cognitive Impairment

China
Lepu Medical Technology (Beijing) Co., Ltd.

Recruiting

Study on the Efficacy and Safety of Rechargeable Implantable DBS System in the Treatment of Parkinson's Disease

Parkinson Disease

China
Lepu Medical Technology (Beijing) Co., Ltd.

Recruiting

Treatment of Urethral Stricture With Urethral Drug Ball

Urethral Stricture Less Than 2 cm

China
Lepu Medical Technology (Beijing) Co., Ltd.

Completed

To Evaluate the Efficacy and Safety of Multi-parameter Non-Invasive Glucose Sensors for for Blood Glucose Measurement

Diabetes Mellitus

China
Lepu Medical Technology (Beijing) Co., Ltd.

Enrolling by invitation

Clinical Trials of Pulsed Sonic Balloon Dilatation Catheter and Pulsed Sonic Generater

Coronary Calcified Disease

China
Lepu Medical Technology (Beijing) Co., Ltd.

Enrolling by invitation

Safety and Efficacy of SinocrownTM Transcatheter Aortic Valve Replacement System

Transcatheter Aortic Valve Replacement

China
Eyebright Medical Technology (Beijing) Co., Ltd.

Completed

Clinical Validation Plan of Capsular Tension Ring (CVPOCTR)

Intraocular Lens Implantation
Beijing Insight Science & Technology Co. Ltd.

Unknown

Effect of SAMe Treatment on Recurrence After Radical Treatment of Primary Hepatic Carcinoma

Primary Liver Cancer
Beijing Insight Science & Technology Co. Ltd.

Unknown

Chinese Liver Cancer Clinical Survey (CLCS)

Primary Liver Cancer
Lepu Medical Technology (Beijing) Co., Ltd.

Unknown

Efficacy and Safety of Nano+ Polymer-free Sirolimus-Eluting Stent: A Optical Coherent Tomography Study

Coronary Artery Disease

Belgium, Netherlands
Beijing Anzhen Hospital
Beijing Wispirit Technology Co., Ltd

Completed

Atrial Fibrillation Follow-up Investigation to Recover Memory and learnING Trial (AFFIRMING)

Cognitive Impairment | Atrial Fibrillation

China
Beijing Friendship Hospital
Newish Technology (Beijing) Co., Ltd.

Unknown

Autologous Tcm Cells Immunotherapy in Patients With Non-Small Cell Lung Cancer (NSCLC)

Carcinoma, Non-Small-Cell Lung

China
Beijing Anzhen Hospital
Beijing Wispirit Technology Co., Ltd

Active, not recruiting

Computerized Cognitive Training in Patients With Coronary Heart Disease and Mild Cognitive Impairment (COG-T CHD)

Coronary Heart Disease | Mild Cognitive Impairment

China
Xuanwu Hospital, Beijing
ChosenMed Technology (Beijing) Co.,Ltd

Unknown

Cancer Genome Atlas of China:Lung Cancer

Non-small Cell Lung Cancer

China
Beijing InnoCare Pharma Tech Co., Ltd.

Recruiting

Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Chronic Primary Immune Thrombocytopenia

Chronic Primary Immune Thrombocytopenia (ITP)

China
Beijing InnoCare Pharma Tech Co., Ltd.

Recruiting

Evaluate the Safety, Tolerability, and Efficacy of ICP-490 in Patients With Relapsed and/or Refractory Multiple Myeloma

Relapsed and/or Refractory Multiple Myeloma

China
Beijing InnoCare Pharma Tech Co., Ltd.

Recruiting

Study to Evaluate Orelabrutinib Tablets in Subjects With Hepatic Impairment and Healthy Subject

Hepatic Impairment

China
Beijing InnoCare Pharma Tech Co., Ltd.

Recruiting

A Study of ICP-192 in Patients With FGFR2-Rearranged Unresectable or Metastatic Intrahepatic Cholangiocarcinoma

Intrahepatic Cholangiocarcinoma (ICC)

China
Beijing InnoCare Pharma Tech Co., Ltd.

Recruiting

A Clinical Trial of ICP-192 in Treated Patients With Advanced Solid Tumors With FGF/FGFR Gene Alterations

Advanced Solid Tumor

China
Beijing InnoCare Pharma Tech Co., Ltd.

Recruiting

ICP-022 Versus Chlorambucil Combined With Rituximab in the Treatment of Untreated CLL/SLL

Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma

China
Beijing InnoCare Pharma Tech Co., Ltd.

Recruiting

A Study of ICP-192 in Patients With Advanced Solid Tumors

Advanced Solid Tumors | Cholangiocarcinoma | Urothelial Carcinoma

Australia, United States
Beijing InnoCare Pharma Tech Co., Ltd.

Recruiting

Clinical Study of ICP-192 in Solid Tumors Patients

Solid Tumor

China
Beijing InnoCare Pharma Tech Co., Ltd.

Completed

A Study of ICP-022 in Patients With R/R DLBCL (DLBCL)

Diffuse Large B Cell Lymphoma

China
Beijing InnoCare Pharma Tech Co., Ltd.

Completed

A Study of ICP-022 in the Treatment of Recurrent or Refractory Waldenstrom Macroglobulinemia

Waldenstrom's Macroglobulinemia Recurrent | Waldenstrom's Macroglobulinemia Refractory

China

Clinical Trials Sponsored by GX pharma technology (beijing) Co., Ltd

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Germany

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations